Animal Healthcare Stocks Plummet, 1 Trillion Won Lost in a Day

Elanco Animal Health Inc. (NYSE: ELAN) shares plunged 8.03% on the New York Stock Exchange on the 11th, closing at $21.75. Its market capitalization fell to about $10.8 billion (roughly KRW 14.7 trillion), wiping out approximately $800 million (around KRW 1.1 trillion) in a single day.

A few days earlier, the company reported first-quarter 2026 revenue of $1.37 billion (about KRW 1.85 trillion), a 15% year-over-year increase, and raised both its full-year revenue guidance and leverage reduction targets. Buoyed by strong sales of new companion animal and livestock products, Elanco had highlighted its growth momentum for 2026, driving its stock up more than 7%; however, it later gave back those gains, increasing volatility.

Headquartered in Indianapolis, Elanco Animal Health is a major animal health company supplying pharmaceuticals for both companion animals and livestock, ranking among the top three in the global animal healthcare market. Originally the animal health division of Eli Lilly, the company spun off and went public on the NYSE in 2019, then grew its product portfolio and scale through multiple acquisitions, including Bayer’s animal health business.